Cannabidiol and tumours
In cell experiments cannabidiol (CBD), a non-psychotropic cannabinoid, inhibited the migration [1] of tumour cells. CBD caused a concentration-dependent inhibition of the migration of glioma cells. Gliomas are malignant brain tumours. These anti-tumour properties of CBD were independent of cannabinoid receptors.
Source: Vaccani A, et al. Br J Pharmacol 2005 Feb 07;
Footnotes
[1] the migration of tumour cells is a criteria for their malignity. Migration can lead to metastases
